AccuDial presents possible solution to overdosage of OTC medication
PALM BEACH GARDENS, Fla. Parents’ confusion over correctly administering over-the-counter medication to their children appears to be shared worldwide, according to a new study presented this week in Lisbon, Portugal, by Rebekah Moles from the University of Sydney.
“We conducted our study over a five-month period, with seven fathers, 53 mothers and 37 day care workers, involving fictitious scenarios regarding children with fever-and-cold symptoms, and asked how they would handle administering medication,” Moles said. Of the 97 caregivers tested, 61% got the dosage wrong.
Almost half (44%) of the caregivers failed to quantify the right quantity and did not give enough medication, while 17% administered an overdose. “Only 14% managed the scenario properly,” Moles said.
In North America, the statistics on overdosing children with OTC medications are similar. According to a report published by the American Medical Association, children between the ages of 2 and 12 years inaccurately are dosed up to 73% of the time, increasing emergency room visits in two-thirds of the cases.
Recently, the daytime television show "The Doctors" featured a segment on weight-based dosing with a new pediatric, weight-based labeling product being brought to market by AccuDial Pharmaceutical. “Studies show that children are given inaccurate doses of over-the-counter medication [more than] 50% of the time,” noted Jim Sears, the show’s host. “As pediatricians, we always dose by weight. Children’s AccuDial’s weight-based label gives specific doses by weight … and it comes with its own dosing spoon, so it’s accurate.”
AccuDial’s products were approved by Health Canada 18 months ago, and presently are under consideration for approval by the Food and Drug Administration.
Nearly $3 million for TB research awarded under FDA’s Critical Path Initiative
SILVER SPRING, Md. The Food and Drug Administration has awarded almost $3 million for tuberculosis research, the agency said Monday.
The FDA said it awarded $2.9 million to six research products to help with the diagnosis, treatment and prevention of TB under its Critical Path Initiative. The disease has seen increasing prevalence around the world, and two recent articles by the agency’s Office of Critical Path programs noted that advances are needed to shorten therapy and treat drug-resistant forms of the disease.
The Critical Path Initiative was created in 2004 to drive innovation in the development, evaluation and manufacturing of medical products.
“FDA recognized an urgent need for the engagement and leadership of public health institutions to promote this critical, but neglected, area of medical therapeutics,” FDA commissioner Margaret Hamburg said.
Market Street pharmacies roll out $4 Rx, OTC medications program
FRISCO, Texas A local supermarket chain is offering $4 prescription and over-the-counter medications at its pharmacies.
Market Street, which operates under the United Supermarkets banner, is extending its health-and-wellness philosophy just in time for the cough-cold season, the company said. Market Street pharmacies service the Dallas-Fort Worth area in Texas.
“We consider our DFW guests to be a part of our Market Street family, and, as such, there’s nothing more important to us than their total health and wellness,” said Tim Purser, business director of pharmacy for Market Street’s parent company United Supermarkets. “While we’ve offered programs in the past, the ‘$4 Rx and over-the-counter medications’ initiative is the most comprehensive savings program we have ever offered our pharmacy guests.”